Wallden B[au] - Search Results

Year	Number of Results
1970	1
1978	1
1980	1
2005	1
2006	1
2010	1
2013	1
2014	2
2015	1
2018	1
2020	1
2024	0

1

Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA).

Danaher P, Warren S, Lu R, Samayoa J, Sullivan A, Pekker I, Wallden B, Marincola FM, Cesano A. Danaher P, et al. Among authors: wallden b. J Immunother Cancer. 2018 Jun 22;6(1):63. doi: 10.1186/s40425-018-0367-1. J Immunother Cancer. 2018. PMID: 29929551 Free PMC article.

2

Development of Gene Expression-Based Biomarkers on the nCounter^® Platform for Immuno-Oncology Applications.

Warren S, Danaher P, Mashadi-Hossein A, Skewis L, Wallden B, Ferree S, Cesano A. Warren S, et al. Among authors: wallden b. Methods Mol Biol. 2020;2055:273-300. doi: 10.1007/978-1-4939-9773-2_13. Methods Mol Biol. 2020. PMID: 31502157

3

Werner syndrome gene variants in human sarcomas.

Hsu JJ, Kamath-Loeb AS, Glick E, Wallden B, Swisshelm K, Rubin BP, Loeb LA. Hsu JJ, et al. Among authors: wallden b. Mol Carcinog. 2010 Feb;49(2):166-74. doi: 10.1002/mc.20586. Mol Carcinog. 2010. PMID: 19824023 Free PMC article.

4

Development and verification of the PAM50-based Prosigna breast cancer gene signature assay.

Wallden B, Storhoff J, Nielsen T, Dowidar N, Schaper C, Ferree S, Liu S, Leung S, Geiss G, Snider J, Vickery T, Davies SR, Mardis ER, Gnant M, Sestak I, Ellis MJ, Perou CM, Bernard PS, Parker JS. Wallden B, et al. BMC Med Genomics. 2015 Aug 22;8:54. doi: 10.1186/s12920-015-0129-6. BMC Med Genomics. 2015. PMID: 26297356 Free PMC article.

5

Prognostic indicators and early home rehabilitation in elderly patients with hip fractures.

Ceder L, Thorngren KG, Wallden B. Ceder L, et al. Among authors: wallden b. Clin Orthop Relat Res. 1980 Oct;(152):173-84. Clin Orthop Relat Res. 1980. PMID: 7438601

6

Antimetastatic gene expression profiles mediated by retinoic acid receptor beta 2 in MDA-MB-435 breast cancer cells.

Wallden B, Emond M, Swift ME, Disis ML, Swisshelm K. Wallden B, et al. BMC Cancer. 2005 Oct 28;5:140. doi: 10.1186/1471-2407-5-140. BMC Cancer. 2005. PMID: 16255778 Free PMC article.

7

PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patients.

Jørgensen CL, Nielsen TO, Bjerre KD, Liu S, Wallden B, Balslev E, Nielsen DL, Ejlertsen B. Jørgensen CL, et al. Among authors: wallden b. Acta Oncol. 2014 Jun;53(6):776-87. doi: 10.3109/0284186X.2013.865076. Epub 2013 Dec 20. Acta Oncol. 2014. PMID: 24359601

8

Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens.

Nielsen T, Wallden B, Schaper C, Ferree S, Liu S, Gao D, Barry G, Dowidar N, Maysuria M, Storhoff J. Nielsen T, et al. Among authors: wallden b. BMC Cancer. 2014 Mar 13;14:177. doi: 10.1186/1471-2407-14-177. BMC Cancer. 2014. PMID: 24625003 Free PMC article.

9

Truncated RAR beta isoform enhances proliferation and retinoid resistance.

Swift ME, Wallden B, Wayner EA, Swisshelm K. Swift ME, et al. Among authors: wallden b. J Cell Physiol. 2006 Dec;209(3):718-25. doi: 10.1002/jcp.20788. J Cell Physiol. 2006. PMID: 17001699

10

[Treatment of hip fractures].

Ceder L, Edwards P, Lidgren L, Walldén B, Wallöe A. Ceder L, et al. Among authors: wallden b. Lakartidningen. 1978 Nov 8;75(45):4134-9. Lakartidningen. 1978. PMID: 713639 Swedish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

11 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year